Early Phase 1 Hidradenitis Suppurativa Clinical Trials
3 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–3 of 3 trials
Recruiting
Early Phase 1
Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
Hidradenitis Suppurativa
University of Minnesota16 enrolled1 locationNCT06058520
Recruiting
Early Phase 1
An Open-label, Time-lagged, Dose-escalation Study to Evalaute the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.
Hidradenitis Suppurativa
University of Alabama at Birmingham12 enrolled1 locationNCT06326476
Recruiting
Early Phase 1
Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1%
Hidradenitis Suppurativa (HS)
Virginia Clinical Research, Inc.15 enrolled1 locationNCT06645821